You are here

  • Home
  • Archive
  • Volume 12, Issue 9
  • Intravenous immunoglobulin and prednisolone to women with unexplained recurrent pregnancy loss after assisted reproductive technology treatment: a protocol for a randomised, double-blind, placebo-controlled trial

Article metrics

Article menu
Obstetrics and gynaecology
Protocol
Intravenous immunoglobulin and prednisolone to women with unexplained recurrent pregnancy loss after assisted reproductive technology treatment: a protocol for a randomised, double-blind, placebo-controlled trial

 

Online download statistics by month:

Online download statistics by month: September 2022 to June 2025

AbstractFullPdf
Sep 202258159747
Oct 202247746660
Nov 202234833948
Dec 202237036934
Jan 202332332114
Feb 202322121633
Mar 2023636221
Apr 2023757122
May 2023453924
Jun 2023524912
Jul 2023443925
Aug 2023635533
Sep 2023393715
Oct 2023534820
Nov 2023755926
Dec 2023433916
Jan 2024494123
Feb 202445319
Mar 2024615031
Apr 2024394027
May 2024373438
Jun 2024403734
Jul 2024655629
Aug 2024444324
Sep 2024414115
Oct 2024565229
Nov 2024837637
Dec 2024716531
Jan 2025494419
Feb 2025635529
Mar 2025746630
Apr 2025474525
May 2025293133
Jun 2025211618
Total37863629931